{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:20:03Z","timestamp":1781623203852,"version":"3.54.5"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T00:00:00Z","timestamp":1454457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2016,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Topical photodynamic therapy (<jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>) is an effective treatment for superficial non\u2010melanoma skin cancers. Two prodrugs, 5\u2010aminolevulinic acid (<jats:styled-content style=\"fixed-case\">ALA<\/jats:styled-content>) and methyl aminolevulinate (<jats:styled-content style=\"fixed-case\">MAL<\/jats:styled-content>), are available for clinical use. There is, however, a lack of studies comparing the clinical effectiveness of these two prodrugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The objective of the study was to compare the clinical response between <jats:styled-content style=\"fixed-case\">ALA<\/jats:styled-content>\u2010 and <jats:styled-content style=\"fixed-case\">MAL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content> when treating actinic keratosis (<jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>), Bowen's disease (<jats:styled-content style=\"fixed-case\">BD<\/jats:styled-content>), nodular basal cell carcinoma (<jats:styled-content style=\"fixed-case\">nBCC<\/jats:styled-content>) and superficial basal cell carcinoma (<jats:styled-content style=\"fixed-case\">sBCC<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>During the period 2002\u20132009, patients with <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> BD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> nBCC<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">sBCC<\/jats:styled-content> were treated with <jats:styled-content style=\"fixed-case\">ALA<\/jats:styled-content>\u2010 and <jats:styled-content style=\"fixed-case\">MAL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content> at the Department of Dermatology at Karlskoga Hospital in Sweden using a fixed protocol. All patients were followed up approximately 6 months after treatment to evaluate the clinical results, which were analysed retrospectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 116 patients with 203 tumours were treated with <jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content> during the study period. <jats:styled-content style=\"fixed-case\">ALA<\/jats:styled-content>\u2010 and <jats:styled-content style=\"fixed-case\">MAL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content> were used for 24 vs. 44 <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content> fields, 9 vs. 18 <jats:styled-content style=\"fixed-case\">BD<\/jats:styled-content> lesions, 19 vs. 25 <jats:styled-content style=\"fixed-case\">nBCC<\/jats:styled-content>s and 25 vs. 39 <jats:styled-content style=\"fixed-case\">sBCC<\/jats:styled-content>s. Response rates with <jats:styled-content style=\"fixed-case\">ALA<\/jats:styled-content>\u2010 and <jats:styled-content style=\"fixed-case\">MAL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content>, respectively, were 63% and 75% for <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>, 89% and 78% for <jats:styled-content style=\"fixed-case\">BD<\/jats:styled-content>, 84% and 84% for <jats:styled-content style=\"fixed-case\">nBCC<\/jats:styled-content> and 88% and 87% for <jats:styled-content style=\"fixed-case\">sBCC<\/jats:styled-content>. There were no statistically significant differences in the complete clinical response rates for <jats:styled-content style=\"fixed-case\">ALA<\/jats:styled-content>\u2010 and <jats:styled-content style=\"fixed-case\">MAL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content> when used for any of the four lesion types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>ALA\u2010 and <jats:styled-content style=\"fixed-case\">MAL<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PDT<\/jats:styled-content> appear to be equally effective in the treatment of <jats:styled-content style=\"fixed-case\">AK<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> BD<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> nBCC<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">sBCC<\/jats:styled-content>. Nevertheless, larger, prospective, randomized and controlled studies should be carried out to confirm these results.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jdv.13558","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T18:28:49Z","timestamp":1454524129000},"page":"420-423","source":"Crossref","is-referenced-by-count":55,"title":["Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non\u2010melanoma skin cancers"],"prefix":"10.1111","volume":"30","author":[{"given":"M.","family":"Tarstedt","sequence":"first","affiliation":[{"name":"Department of Dermatology Karlskoga Hospital Karlskoga Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gillstedt","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Sahlgrenska University Hospital Institute of Clinical Sciences at the Sahlgrenska Academy University of Gothenburg Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.\u2010M.","family":"Wennberg Lark\u00f6","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Sahlgrenska University Hospital Institute of Clinical Sciences at the Sahlgrenska Academy University of Gothenburg Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Paoli","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology Sahlgrenska University Hospital Institute of Clinical Sciences at the Sahlgrenska Academy University of Gothenburg Gothenburg Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,3]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.06.006"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08882.x"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12031"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.04022.x"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2014.03.009"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0098"},{"key":"e_1_2_5_8_1","first-page":"44","article-title":"Therapeutic and aesthetic uses of photodynamic therapy part five of a five\u2010part series: ALA\u2010PDT and MAL\u2010PDT what makes them different","volume":"2","author":"Gold MH","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1011-1344(01)00173-7"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09437.x"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1068"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10613.x"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2014.26.3.321"},{"key":"e_1_2_5_14_1","first-page":"642","article-title":"Similar effectiveness of methyl aminolevulinate and 5\u2010aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma","volume":"5","author":"Kuijpers DI","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07946.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13326"},{"key":"e_1_2_5_17_1","first-page":"50","article-title":"Photodynamic therapy in the treatment of basal cell carcinoma","volume":"6","author":"Matei C","year":"2013","journal-title":"J Med Life"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04175.x"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12343"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60761-697-9_7"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1039\/C2PP25287B"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1448"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13558","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13558","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T16:08:00Z","timestamp":1695485280000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["10.1111\/jdv.13558"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13558","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,3]]}}}